Gene · 6872
Papers2,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional networks of the human bromodomain-containing proteins. | Front Bioinform | 2022 | 36304339 | PubTator, text mining | PubMed |
| Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study. | Int J Mol Sci | 2022 | 36293304 | PubTator, text mining | PubMed |
| Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma. | Cancers (Basel) | 2022 | 36291846 | PubTator, text mining | PubMed |
| Nuclear Proteomics of Induced Leukemia Cell Differentiation. | Cells | 2022 | 36291090 | PubTator, text mining | PubMed |
| Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma. | Front Oncol | 2022 | 36276071 | PubTator, text mining | PubMed |
| Establishment of in vivo proximity labeling with biotin using TurboID in the filamentous fungus Sordaria macrospora. | Sci Rep | 2022 | 36272986 | PubTator, text mining | PubMed |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2022 | 36243813 | PubTator, text mining | PubMed |
| Selecting for CRISPR-Edited Knock-In Cells. | Int J Mol Sci | 2022 | 36233222 | PubTator, text mining | PubMed |
| Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection. | Int J Mol Sci | 2022 | 36232610 | PubTator, text mining | PubMed |
| Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma. | Int J Mol Sci | 2022 | 36232418 | PubTator, text mining | PubMed |
| Epigenetic disorders: Lessons from the animals-animal models in chromatinopathies. | Front Cell Dev Biol | 2022 | 36225316 | PubTator, text mining | PubMed |
| Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers. | Neuroimage Clin | 2022 | 36223668 | PubTator, text mining | PubMed |
| The Dystonias. | Continuum (Minneap Minn) | 2022 | 36222773 | PubTator, text mining | PubMed |
| Enhancing sampling of water rehydration upon ligand binding using variants of grand canonical Monte Carlo. | J Comput Aided Mol Des | 2022 | 36198874 | PubTator, text mining | PubMed |
| A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. | Front Immunol | 2022 | 36189307 | PubTator, text mining | PubMed |
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
| Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. | Front Pharmacol | 2022 | 36188615 | PubTator, text mining | PubMed |
| The synergistic interaction landscape of chromatin regulators reveals their epigenetic regulation mechanisms across five cancer cell lines. | Comput Struct Biotechnol J | 2022 | 36187922 | PubTator, text mining | PubMed |
| Bioinformatic Data Mining for Candidate Drugs Affecting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) in Cancer Patients. | Dis Markers | 2022 | 36157219 | PubTator, text mining | PubMed |
| Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension. | Front Genet | 2022 | 36147486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6872/papers?page=16